Evolution of the Average Target: Xylem Inc.

Evolution of the Average Target - Xylem Inc.

Evolution of the Target Price: Xylem Inc.

Evolution of the Target Price - Xylem Inc.

Changes in Analyst Recommendations: Xylem Inc.

97bf65b9eaffb6f8f33023c8a723b._H9vZ2QX426fe6hke_3scbviKdU9wIVxNM1fnt1_rM8.0U8FDDtV2lzQTMEnKJaLNs-QYoZqr8syePQK8-ge5ISUBSUjBVOHDNEryw~3c95cf273515c332f6605228fcd2fcdf
29/10 UBS Adjusts Xylem Price Target to $99 From $112, Maintains Neutral Rating MT
29/10 Not All AI Billions Are Equal Zonebourse
29/10 Barclays Downgrades Xylem to Equalweight From Overweight, Price Target is $104 MT
29/10 Analyst recommendations: Boston Scientific, Hilton, Kla Corporation, Fortinet, Microsoft… Zonebourse
28/10 Oppenheimer Adjusts Price Target on Xylem to $135 From $150, Maintains Outperform Rating MT
28/10 RBC Cuts Price Target on Xylem to $125 From $135, Keeps Outperform Rating MT
28/10 Citigroup Adjusts Price Target on Xylem to $130 From $148 MT
28/10 Analyst recommendations: Boeing, Qiagen, Spotify, Applovin, Fedex… Zonebourse
28/10 BNP Paribas Adjusts Price Target on Xylem to $135 From $145 MT
28/10 Goldman Sachs Adjusts Price Target on Xylem to $138 From $160 MT
28/10 JPMorgan Downgrades Xylem to Underweight From Neutral, $90 Price Target MT
19/10 JPMorgan Adjusts Price Target on Xylem to $118 From $137 MT
15/10 Mizuho Adjusts Price Target on Xylem to $110 From $130 MT
14/10 Xylem's YTD Stock Performance Reflects Fears Around Sustained Top-Line Pressure, Oppenheimer Says MT
14/10 Oppenheimer Adjusts Xylem Price Target to $150 From $158, Maintains Outperform Rating MT
14/10 RBC Capital Adjusts Xylem Price Target to $135 From $164, Maintains Outperform Rating MT
12/10 Citigroup Adjusts Price Target on Xylem to $148 From $172 MT
05/10 UBS Adjusts Price Target on Xylem to $112 From $138, Keeps Neutral Rating MT
01/10 BNP Paribas Adjusts Price Target on Xylem to $145 From $160, Maintains Outperform Rating MT
24/08 Jefferies Adjusts Price Target on Xylem to $150 From $145 MT
13/08 UBS Adjusts Price Target on Xylem to $138 From $135, Keeps Neutral Rating MT
12/08 Argus Adjusts Price Target on Xylem to $140 From $125, Maintains Buy Rating MT
30/07 UBS Adjusts Price Target on Xylem to $135 From $129, Maintains Neutral Rating MT
29/07 Xylem's Guidance Boost Driven by Buybacks, Bolt-On Acquisition, RBC Says MT
29/07 RBC Raises Price Target on Xylem to $164 From $159, Keeps Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+38.19%
+28.09%
+22.81%
-2.03%
-1.62%
+36.07%
+26.28%
+20.14%
+17.55%
+14.95%
Average +20.04%
Weighted average by Cap. +19.41%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
92.40USD
Average target price
127.69USD
Spread / Average Target
+38.19%
High Price Target
180.00USD
Spread / Highest target
+94.81%
Low Price Target
90.00USD
Spread / Lowest Target
-2.60%

Analyst Consensus Detail

Analyst consensus - Xylem Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Xylem Inc.
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Xylem Inc.
  1. Stock Market
  2. Stocks
  3. XYL Stock
  4. Consensus Xylem Inc.